Fashion e-tailer Myntra, which is a part of Flipkart Group, said 50 per cent of shoppers on its platform on the first day (October 16) of its sale were from tier-2 and 3 cities

The committee has recommended that the existing personal safety protocols need to continue in full measure, otherwise the country will see a sharp rise in infections

The state government has been carrying out relief measures in the rain-affected areas, even as some localities, close to water bodies, remained in water

The highly volatile stock today touched an intraday high of Rs 383.4, rising 4.67% as against the previous close of Rs 366.30 on BSE. The stock also touched an intraday high and low of Rs 385 and Rs 370, respectively

India Stock Market Highlights Today: IndusInd Bank, Tata Steel, Infosys, ONGC, BPCL, Cipla, Kotak Bank, NTPC and Bharti Airtel were among prominent gainers. On the other hand, Asian Paints, Sun Pharma, Nestle, RIL, M&M, HCL Tech were among the top losers.

How a handful of technology companies are becoming central to imparting management education

As part of its effort to fast-track COVID-19 vaccine development, Hyderabad-based Bharat Biotech has cut the size of Phase 2 clinical trials of its indigenous coronavirus vaccine Covaxin by half; Bicycle sales in India have grown by over two-folds in the last five months as people are opting for this cheapest mode of transport to cover short to medium distance; Russia on Wednesday announced that it has granted regulatory approval to another COVID-19 vaccine named EpiVacCorona. Watch this and more on News Blast.Also Read: Need to develop more disease-specific health insurance policies: IRDAI

COVID-19 vaccine: Bharat Biotech fast-tracks Covaxin's trials, halves Phase 2 test sizeAs part of its effort to fast-track COVID-19 vaccine development, Hyderabad-based Bharat Biotech has cut the size of Phase 2 clinical trials of its indigenous coronavirus vaccine Covaxin by half. The vaccine, which Bharat Biotech is developing in collaboration with the country's apex medical research body - Indian Council of Medical Research (ICMR), will now be tested on 380 healthy volunteers in phase 2 a...

Coronavirus vaccine update: Bharat Biotech is ready to start Covaxin's Phase 3 trail to test the vaccine on about 28,500 volunteers

Under Phase-II of the FAME India Scheme, Government of India (GoI) intends to support the development of EV charging infrastructure by extending capital grant to organisations for promoting the use of Electric Vehicles (EVs)

Hyderabad floods: The visual has surfaced from Barkas, near Falaknuma, showing a man trying to hold on to a pole that comes in the path but fails as he is pushed and eventually swept away by a strong floodwater current

While the origin of biryani has always been under debate amid lovers of the dish, the new Boycott Biryani challenge threw open Pandora's box

Hyderabad rain: At least nine people have died, including a two month-old-child after a wall collapsed and fell on 10 houses in Hyderabad due to three continuous days of rainfall

Hyderabad rain: At least nine people have died, including a two month-old-child after a wall collapsed and fell on 10 houses in Hyderabad due to three continuous days of rainfall

Hyderabad rain: At least nine people have died, including a two month-old-child after a wall collapsed and fell on 10 houses in Hyderabad due to three continuous days of rainfall

Hyderabad Rains 2020: Telangana Chief Secretary Somesh Kumar has directed all Collectors, Commissioners of Police and Superintendents of Police and the complete district administration to be on high alert

The IPO was subscribed 9.51 times. The initial public offering (IPO) with a price band of Rs 116- 120 per share, was scheduled to close on October 1 but was extended till October 7 amid lacklustre response

In most cases, AstraZeneca gathered information about marketing approvals from the state departments by using the RTI (Right to Information Act) route

All ministries and departments have been asked to expedite asset monetisation exercise and meet the timelines set for each project

\"We're expecting that early next year we should have vaccine in the country from maybe more than one source,\" says union health minister Harsh Vardhan